logo-loader
viewMarrone Bio Innovations

Full interview: Marrone Bio Innovations grows revenue to $7M in 3Q

Marrone Bio Innovations Inc (NASDAQ:MBII) CEO Pam Marrone tells Proactive the bioprotection and plant health company posted third-quarter results that saw revenue jump 28% year-over-year on the back of the company’s specialty crop and cultivated garden businesses.

Marrone says revenue was $7 million for Q3, up from $5.4 million a year earlier, beating Street estimates of $6.95 million.

Quick facts: Marrone Bio Innovations

Price: 1.23 USD

NASDAQ:MBII
Market: NASDAQ
Market Cap: $171.35 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Marrone Bio Innovations named herein, including the promotion by the Company of Marrone Bio Innovations in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Marrone Bio Innovations receives approval from EPA for...

Marrone Bio Innovations (NASDAQ: MBII) CEO and Founder Dr Pam Marrone joined Steve Darling from Proactive Vancouver on Skype with news that two of its biofungicide products Stargus and Regalia have been approved by the U.S. Environmental Protection Agency for indoor and outdoor use on hemp...

on 01/07/2020

2 min read